Latest from the Blog

1. January 8, 2020

   NBTS Brain Tumor Clinical Trials Report: Q4 2019 (Including Year-End Update on Phase III Trials)

   

   Brain tumor clinical trials open around the country all the time, and it can be hard for patients and care partners to keep track of new opportunities to consider participation in leading-edge clinical research. This report, generated by the National Brain Tumor Society, provides a summary of clinical trials that have started or begun recruitment […]

   Read more | 

   Tags: astrocytoma, brain cancer, brain tumor, Cancer, chemotherapy, Clinical trials, DIPG, GBM, glioblastoma, glioma, high-grade glioma, immunotherapy, low-grade glioma, meningioma, NCI, neurosurgery, NIH, Oligodendroglioma, pediatric brain tumor, pediatric cancer, precision medicine, Treatment
2. January 7, 2020

   What the Brain Tumor Community Was Reading in 2019

   

   Below are the “Top 10” most-read blogs and news stories from the NBTS website over the course of 2019. Included are recaps of the inspiring moments in the brain tumor community, promising updates on advances we’re making together, and powerful testimonials from patients and families impacted by brain tumors. 1. Glioblastoma Awareness Day Resolution Passes […]

   Read more | 

   Tags: advocacy, brain cancer, brain tumor, brain tumor community, Cancer, childhood cancer, Clinical trials, Community, Defeat GBM, GBM, glioblastoma, immunotherapy, pediatric brain tumor, pediatric cancer, Treatment
3. January 6, 2020

   From the CEO’s Desk: A New Year’s Message

   

   Dear Friend, Thank you so much for all you have done this past year to reach our shared vision of conquering and curing brain tumors — once and for all. Your financial support, time, advocacy, and community leadership has resulted in making 2019 truly a year of progress. National Brain Tumor Society’s strategy to realize […]

   Read more | 

   Tags: advocacy, brain cancer, brain tumor, brain tumor community, Ependymoma, immunotherapy, meningioma, Treatment